Dividend Advisor Hotline – Friday, May 14, 2021

ALGONQUIN POWER & UTILITIES CORP., $18.60, Toronto symbol AQN, is a buy.

Algonquin has two main businesses: the Regulated Services Group provides regulated electricity, gas, water distribution and wastewater collection services to 1.9 million customers in Canada, the U.S., Chile and Bermuda; and the Renewable Power… Read More

Q: Compass Pathways looks to be in an interesting new market for magic mushroom drugs. What do you think of the shares as an investment? Thank you.

A: Compass Pathways plc (ADR), $36.19, symbol CMPS on Nasdaq (Shares outstanding: 36.7 million; Market cap: $1.4 billion; www.compasspathways.com), was founded in 2015. The company is now testing the psychoactive compound psilocybin, sometimes referred to as “magic mushrooms,” as a therapy for treatment-resistant depression, or… Read More

AbbVie diversifies to cut your risk

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc.
Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think… Read More

Canada’s new marijuana laws don’t make Canadian Marijuana stocks a ‘buy’

Canada’s new marijuana laws don’t make Canadian Marijuana stocks a ‘buy’

Why decriminalization of marijuana and investment by big Canadian names doesn’t change our opinion of Canadian Marijuana stocks
Interest in Canadian marijuana stocks stems from Fall 2018’s legalization of recreational cannabis. Today, investors continue to search for ways to tap in to those sales and profit from future growth. The federal government’s legislation… Read More